Sequent Scientific acquires 24.78% stake in Alivira

01 Apr 2015 Evaluate

Sequent Scientific has acquired 7,400,000 equity shares of Alivira Animal Health (Alivira) representing 24.78% of paid up equity capital from Shasun Pharmaceuticals. Post this acquisition, the company now holds 91.92% of paid up equity capital of Alivira.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.



Viyash Scientific Share Price

203.00 0.95 (0.47%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×